ARTCLINE GmbH develops innovative therapy methods for intensive care medicine based on immune cells. Our current main project is the development of the so-called ARTICE technology for the treatment of bacterial sepsis.
ARTCLINE's vision is the development of innovative immune cell-based therapy approaches and to make the technology available to physicians and hospitals worldwide. The safety and effectiveness of the therapy is our top priority.
Our extensive cell biological, clinical and industrial experience in the fields of immunology, sepsis diagnostics and therapy help us to realize our vision. Together with scientists and partners, we focus our research activities on the root causes and correlations of sepsis.
For many years, the founders and the team of ARTCLINE GmbH have been successfully involved in the transfer of medical inventions from university research to industrial application. We have an extensive network and long standing experience in the development and successful marketing of medical devices and drugs.
Company Details
- Employees
- 17
- Founded
- -
- Address
- Schillingallee 68, Rostock,mecklenburg-West Pomerania 18057,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.artcline.de
- Keywords
- IT Consulting.
- HQ
- Rostock, Mecklenburg-West Pomerania
Artcline Gmbh Questions
Artcline Gmbh's website is http://www.artcline.de
Artcline Gmbh's LinkedIn profile is https://de.linkedin.com/company/artcline
Artcline Gmbh has
17 employees.
View email and phone details for 17
employees at Artcline Gmbh.
Artcline Gmbh's industry is
Biotechnology Research
Artcline Gmbh's top competitors are
Hamandi Corporation,
Allegro Smart Inc.,
Hanse- Und Universitätsstadt Rostock,
Niyok,
A&o Shearman,
Anocca,
Döhlergroup,
Neatec Vertriebsgesellschaft Für Orthopädische Erzeugnisse Mbh,
Tagung Derm,
Alanta Health Group Gmbh.
Artcline Gmbh's categories are Biotechnology Research
Artcline Gmbh's founding year is 2007
